Zheng XL. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med. 2015;66:211-25. doi: 10.1146/annurev-med-061813-013241. PMID:25587650.

Zheng XL.Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998 Nov 26;339(22):1585-94. PMID: 9828246.

Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996 May 15;87(10):4235-44. PMID: 8639782.

Furlan M, Robles R, Solenthaler M, Lämmle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura . Blood. 1998 Apr 15;91(8):2839-46. PMID: 9531594.

Gerritsen HE, Robles R, Lämmle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001 Sep 15;98(6):1654-61. doi: 10.1182/blood.v98.6.1654. PMID: 11535494.

Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001 Sep 15;98(6):1662-6. doi: 10.1182/blood.v98.6.1662. PMID: 11535495

Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001 Oct 4;413(6855):488-94. PMID:11586351.

Ostertag EM, Kacir S, Thiboutot M, Gulendran G, Zheng XL, Cines DB, Siegel DL. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro. Transfusion. 2016 Jul;56(7):1763-74. doi: 10.1111/trf.13584. Epub 2016 Apr 4. PMID: 27040144.

Klaus C, Plaimauer B, Studt JD, Dorner F, Lämmle B, Mannucci PM, Scheiflinger F. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood. 2004 Jun 15;103(12):4514-9. doi: 10.1182/blood-2003-12-4165. Epub 2004 Feb 19. PMID: 14976043.

Zhou W, Dong L, Ginsburg D, Bouhassira EE, Tsai HM. Enzymatically active ADAMTS13 variants are not inhibited by anti-ADAMTS13 autoantibodies: a novel therapeutic strategy? J Biol Chem. 2005 Dec 2;280(48):39934-41. doi: 10.1074/jbc.M504919200. Epub 2005 Oct 3. PMID: 16203734.

Jian C, Xiao J, Gong L, Skipwith CG, Jin SY, Kwaan HC, Zheng XL. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2012 Apr 19;119(16):3836-43. doi: 10.1182/blood-2011-12-399501. Epub 2012 Jan 30. PMID: 22289888.

Banno F, Kokame K, Okuda T, Honda S, Miyata S, Kato H, Tomiyama Y, Miyata T. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood. 2006 Apr 15;107(8):3161-6. doi: 10.1182/blood-2005-07-2765. Epub 2005 Dec 20. PMID: 16368888.

Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1901-8. doi: 10.1161/ATVBAHA.107.145797. Epub 2007 May 24. PMID: 17525362.

Schiviz A, Wuersch K, Piskernik C, Dietrich B, Hoellriegl W, Rottensteiner H, Scheiflinger F, Schwarz HP, Muchitsch EM. A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13. Blood. 2012 Jun 21;119(25):6128-35. doi: 10.1182/blood-2011-09-380535. Epub 2012 Apr 23. PMID: 22529289.

Feys HB, Roodt J, Vandeputte N, Pareyn I, Lamprecht S, van Rensburg WJ, Anderson PJ, Budde U, Louw VJ, Badenhorst PN, Deckmyn H, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus). Blood. 2010 Sep 23;116(12):2005-10. doi: 10.1182/blood-2010-04-280479. Epub 2010 Jun 15. PMID: 20551375.